VSHP Webinar 

Thursday, December 8, 2022 – 12:00pm-1:00 pm

Dynamics in the Biosimilar Landscape: Recent and Upcoming Changes

Speaker:

Mark Maas, PharmD, BCPS

Clinical Pharmacy Specialist, Drug Information and Policy

Department of Pharmacy Services, VCU Health System

Presentation Objectives for Pharmacists:

• Define biosimilar, interchangeable, and unbranded biologic.
• Determine the optimal infliximab biosimilar for your institution.
• Prepare your institution for the marketing of adalimumab biosimilars.

Presentation Objectives for Pharmacy Technicians:

• Define biosimilar, interchangeable, and unbranded biologic.
• List the steps taken to assess infliximab biosimilars at your institution.
• Prepare your institution for the marketing of adalimumab biosimilars.

Accreditation:

Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1.0 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.

ACPE UAN:  0108-0000-22-058-L01-P; 0108-0000-22-058-L01-T

Activity type: Knowledge-based

This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20.

To register: https://us02web.zoom.us/webinar/register/WN_gj3kh7aSTTmHV5loL-arbg